nicotinamide mononucleotide has been researched along with Barth Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bessert, D; Damschroder, D; Greenberg, ML; Ji, J; Lazcano, P; Reynolds, CA; Wessells, R | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Barth Syndrome
| Article | Year |
|---|---|
NAD supplementation improves mitochondrial performance of cardiolipin mutants.
Topics: Barth Syndrome; Cardiolipins; Dietary Supplements; Humans; Mitochondria; NAD; Nicotinamide Mononucleotide | 2022 |